NEW BIOCHIP TO ATTACK TUBERCULOSIS

Abstract

A jointly developed biochip technology to help identify and eradicate drug-resistant strains of tuberculosis will be used by researchers at the U.S. Department of Energy's Argonne National Laboratory and the Russian Academy of Science's Engelhardt Institute of Molecular Biology. The project was undertaken by American and Russian scientists trying to stem outbreaks of a disease that is currently infecting thousands of prisoners in Russian jails, and is making an alarming comeback in the United States. At the Argonne National Lab, researchers want to put the bioarray-type biochip technology they co-designed with the Engelhardt Institute through its paces to head off a worldwide outbreak of tuberculosis.